These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12366713)

  • 21. Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer.
    Ceballos-Viro J; López-Picazo JM; Pérez-Gracia JL; Sola JJ; Aisa G; Gil-Bazo I
    World J Gastroenterol; 2009 May; 15(18):2290-2. PubMed ID: 19437574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Kim JS; Hahn JS; Park SY; Kim Y; Park IH; Lee CK; Cheong JW; Lee ST; Min YH
    Yonsei Med J; 2007 Feb; 48(1):78-89. PubMed ID: 17326249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
    Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.
    Ikeda K; Shiga Y; Takahashi A; Kai T; Kimura H; Takeyama K; Noji H; Ogawa K; Nakamura A; Ohira H; Sato Y; Maruyama Y
    Leuk Lymphoma; 2006 Jan; 47(1):155-7. PubMed ID: 16321842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
    Law JK; Ho JK; Hoskins PJ; Erb SR; Steinbrecher UP; Yoshida EM
    Leuk Lymphoma; 2005 Jul; 46(7):1085-9. PubMed ID: 16019563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosing cholestatic hepatitis: a report of three cases.
    Lee HK; Yoon GS; Min KS; Jung YW; Lee YS; Suh DJ; Yu E
    J Korean Med Sci; 2000 Feb; 15(1):111-4. PubMed ID: 10719821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
    Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
    Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The difficulties of managing severe hepatitis B virus reactivation.
    Roche B; Samuel D
    Liver Int; 2011 Jan; 31 Suppl 1():104-10. PubMed ID: 21205146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus.
    Walsh KM; Woodall T; Lamy P; Wight DG; Bloor S; Alexander GJ
    Gut; 2001 Sep; 49(3):436-40. PubMed ID: 11511568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy.
    Cil T; Altintas A; Pasa S; Bayan K; Ozekinci T; Isikdogan A
    Leuk Lymphoma; 2008 May; 49(5):939-47. PubMed ID: 18464113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient.
    Law JK; Ali JA; Harrigan PR; Sherlock CH; Savage KJ; Yoshida EM
    Am J Hematol; 2006 Dec; 81(12):969-72. PubMed ID: 16937392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
    Yeo W; Chan PK; Zhong S; Ho WM; Steinberg JL; Tam JS; Hui P; Leung NW; Zee B; Johnson PJ
    J Med Virol; 2000 Nov; 62(3):299-307. PubMed ID: 11055239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.
    Han DJ; Kim TH; Park SK; Lee SK; Kim SB; Yang WS; Park JS; Jung JG; Yu ES; Kim SC
    Transplantation; 2001 Feb; 71(3):387-94. PubMed ID: 11233898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Sprengers D; van Gelder T; Zondervan PE; Niesters HG; Janssen HL; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1380-4. PubMed ID: 12162178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Endo T; Sakai T; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T; Sawada K
    Bone Marrow Transplant; 2001 Feb; 27(4):433-6. PubMed ID: 11313673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of fibrosing cholestatic hepatitis with lamivudine.
    Chan TM; Wu PC; Li FK; Lai CL; Cheng IK; Lai KN
    Gastroenterology; 1998 Jul; 115(1):177-81. PubMed ID: 9649474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis.
    Saleh F; Ko HH; Davis JE; Apiratpracha W; Powell JJ; Erb SR; Yoshida EM
    Ann Hepatol; 2007; 6(3):186-9. PubMed ID: 17786148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.